I-Mab Biopharma
I-Mab Biopharma has developed TJM2, a neutralising antibody, as a treatment for patients suffering severe cases of the coronavirus infection.
Rankings by 
Национальный рейтинг
20th
in ChinaРегиональный рейтинг
47th
in East AsiaГлобальный рейтинг
1125th
worldwide